Follow us on  LinkedFit for Health LinkedIN

Frequently Asked Questions (FAQ) - Innovative Medicines Initiative (IMI)

Answer: 

For topic 1 and 2: Sanofi (Coordinator), Novo Nordisk (Co-coordinator), Eli Lilly(To be confirmed), Other potential partners are still under consideration.

Answer: 

The topic of personalised medicine is central to many IMI projects, for an overview, please consult the IMI projects database at http://www.imi.europa.eu/content/ongoing-projects

Answer: 

The RADAR topic is still under discussion between the industrial partners in order to ensure the involvement of other industrial sectors such as the imaging companies.

Answer: 

The IMI Project COMBACTE deals with antimicrobial resistance (AMR) http://www.imi.europa.eu/content/combacte

Answer: 

According to the Horizon 2020 „minimum conditions“ for participation,(a) at least three legal entities shall participate in an action;(b) three legal entities shall each be established in a different Member State or associated country;c) the three legal entities referred to in point (b) shall be independent of each other

Question details: 
I am in the staff of a university hospital that is looking to increase participation in European research programs. Do you have information on which SME from Italy participating in IMI projects in the health sector?
Answer: 

For this question, I would recommend to contact the Italian Delegate to the IMI States Represenatives Group, Giovina RUBERTI (grubertiAT ibc.cnr.it ). Furthermore, you can check all running IMI projects at http://www.imi.europa.eu/content/ongoing-projects

IMI-Partnering-Database
Partner search for the 1st IMI2 Call via: http://www.imi-partnering.de